This interview covers symptom management and quality-of-life outcomes in cancer clinical trials, which are being incorporated more readily as secondary and sometimes primary trial endpoints.
Bryce B. Reeve, PhD
Advertisement
Articles by Bryce B. Reeve, PhD
This interview covers symptom management and quality-of-life outcomes in cancer clinical trials, which are being incorporated more readily as secondary and sometimes primary trial endpoints.
Advertisement
Latest Updated Articles
Patient Quality of Life Endpoints in Oncology Trials, Part IMarch 29th 2013
Advertisement
Advertisement
Trending on CancerNetwork
1
A Brief History of Major Events in Oncology
2
Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer
3
3 Things You Should Know About TROP2-Directed Antibody-Drug Conjugates in the Frontline Treatment of Metastatic Triple-Negative Breast Cancer
4
This Week in Oncology: Real-World NSCLC Care and AACR 2026 Updates
5